other material
confidence high
sentiment neutral
materiality 0.50
PAVmed elects to receive $4.68M in Lucid common stock for management fees
Lucid Diagnostics Inc.
- PAVmed issued 3,331,771 shares of Lucid common stock in lieu of $4,675,256 in fees and reimbursements.
- Fees accrued under management services and payroll reimbursement agreements from Oct 1, 2022 to Dec 31, 2022.
- PAVmed will distribute the shares to its stockholders on or before February 15, 2024.
- This unregistered equity issuance follows terms previously disclosed in the MSA and PBERA.